Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: Randomised screening trial

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Miller, Anthony B ^a   Wall, Claus ^a   Baines, Cornelia J ^a   Sun, Ping ^b   To, Teresa ^c   Narod, Steven A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANADA; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; FOLLOW UP; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TUMOR INVASION;

ADULT; BREAST NEOPLASMS; CANADA; EARLY DETECTION OF CANCER; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PHYSICAL EXAMINATION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS;

EID: 84896690485     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g366     Document Type: Article

References (26)

1. Miller AB. Conundrums in screening for cancer. Mini review. Int J Cancer 2010;126: 1039-46.
2. Moss S. Over-diagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res 2005;7: 230-4. (Pubitemid 41387438)
3. Welch HG. Over-diagnosis and mammography screening. BMJ 2009;339: 182-3.
4. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years. CMAJ 1992;147: 1459-76. (Pubitemid 23008476)
5. Miller AB, Baines CJ, To T, Wall C. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. CMAJ 1992;147: 1477-88. (Pubitemid 23008477)
6. Miller AB, To T, Baines CJ, Wall C. Canadian National Breast Screening Study-2: 13-year results of a randomized trial in women age 50-59 years. J Natl Cancer Inst 2000;92: 1490-9.
7. Miller AB, To T, Baines CJ, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137: 305-12. (Pubitemid 34977131)
8. Leger JL, Naimark AP, Beique R, McFarlane DV, Miller S, Miller AB. Report of the "ad hoc" committee on mammography. J Can Assoc Radiol 1974;25: 3-21.
9. Report of the Working Group to review the National Cancer Institute-American Cancer Society Breast Cancer Detection Demonstration Projects. J Natl Cancer Inst 1979;62: 641-709.
10. Shapiro S, Strax P, Venet L. Periodic breast cancer screening in reducing mortality from breast cancer. JAMA 1971;215: 1777-85.
11. Shapiro S. Evidence on screening for breast cancer from a randomized trial. Cancer 1977;39: 2772-82. (Pubitemid 8130392)
12. Tarone RE. The excess of patients with advanced breast cancer in young women screened with mammography in the Canadian National Breast Screening Study. Cancer 1995;75: 997-1003.
13. Mukherjee S. The emperor of all maladies. A biography of cancer. Simon and Shuster, 2010.
14. Canadian Breast Cancer Screening Database (CBCSD). Operational procedures and input data dictionary. Version 6. Public Health Agency of Canada, 2012.
15. Roberts RS, Julian JA, Sweezey D, Muir DC, Shannon HS, Mastromatteo E. A study of mortality in workers engaged in the mining, smelting, and refining of nickel. I: methodology and mortality by major cause groups. Toxicol Ind Health 1989;5: 957-74. (Pubitemid 20177007)
16. Baines CJ, Miller AB, Kopans DB, Moskowitz M, Sanders DE, Sickles EA, et al. Canadian National Breast Screening Study: assessment of technical quality by external review. Am J Roentgenol 1990: 155: 743-7. (Pubitemid 20305031)
17. Miller AB, Baines CJ, Sickles EA. Canadian National Breast Screening Study. Am J Roentgenol 1990;155: 1133-4. (Pubitemid 20357021)
18. Baines CJ, McFarlane DV, Wall C. Audit procedures in the National Breast Screening Study: mammography interpretation. Can Assoc Radiol J 1986;37: 256-60. (Pubitemid 17056974)
19. Tabár L, Vitak B, Chen TH, Yen AM, Cohen A, Tot T, et al. Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. Radiology 2011;260: 658-63.
20. Tabar L, Chen H-H T, Duffy SW, Kruesmo UB. Primary and adjuvant therapy, prognostic factors and survival in 1053 breast cancers diagnosed in a trial of mammography screening. Jpn J Clin Oncol 1999;2129: 608-16.
21. Narod SA. On being the right size: a reappraisal of mammography trials in Canada and Sweden. Lancet 1997;349: 1846. (Pubitemid 27257578)
22. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 2012;367: 1998-2005.
23. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006;332: 689-92.
24. Zahl PH, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study. Lancet Oncol 2011;12: 1118-24.
25. Narod SA. Tumour size predicts long-term survival among women with lymph node-positive breast cancer. Curr Oncol 2012;19: 249-53.
26. Gøtzsche PC, Jørgensen KJ, Zahl P-H, Mæhlen J. Why mammography screening has not lived up to expectations from the randomised trials. Cancer Causes Control 2012;23: 15-21.